Terms: = Kidney tumors AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
9 results:
1. [Clinicopathological features and diagnosis of pericytic tumors of the kidney].
He YL; Zou YW; Hu YJ; Wu J; Zhang W; Yu WJ; Li YJ; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):987-992. PubMed ID: 36207911
[No Abstract] [Full Text] [Related]
2. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
[TBL] [Abstract] [Full Text] [Related]
3. Perivascular pdgfr-β is an independent marker for prognosis in renal cell carcinoma.
Frödin M; Mezheyeuski A; Corvigno S; Harmenberg U; Sandström P; Egevad L; Johansson M; Östman A
Br J Cancer; 2017 Jan; 116(2):195-201. PubMed ID: 27931046
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic clear cell renal carcinoma - an unusual response to Temsirolimus in second line therapy.
Stanculeanu DL; Lazescu A; Zob DD; Bunghez R; Anghel R; Poteca TD
J Med Life; 2016; 9(2):193-8. PubMed ID: 27453754
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
[TBL] [Abstract] [Full Text] [Related]
6. Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer.
Yuasa T; Takahashi S; Hatake K; Yonese J; Fukui I
Cancer Sci; 2011 Nov; 102(11):1949-57. PubMed ID: 21812860
[TBL] [Abstract] [Full Text] [Related]
7. Sustained response following sorafenib therapy in an older adult patient with advanced renal cancer on hemodialysis: a case report.
Castagneto B; Stevani I; Giorcelli L; Montefiore F; Bigatti GL; Pisacco P; Cosimi MF
Med Oncol; 2011 Dec; 28(4):1384-8. PubMed ID: 20552299
[TBL] [Abstract] [Full Text] [Related]
8. Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.
Stec R; Grala B; Maczewski M; Bodnar L; Szczylik C
J Exp Clin Cancer Res; 2009 Oct; 28(1):134. PubMed ID: 19811659
[TBL] [Abstract] [Full Text] [Related]
9. [Molecular pathways of tumour angiogenesis and new targeted therapeutic approaches in renal cancer].
Fergelot P; Rioux-Leclercq N; Patard JJ
Prog Urol; 2005 Dec; 15(6):1021-9. PubMed ID: 16429647
[TBL] [Abstract] [Full Text] [Related]